Asia-Pacific PCR multiplex assays market is projected to register a substantial CAGR in the forecast period 2019 to 2026. The new market report contains data for the historic year 2017, the base year of calculation is 2018 and the forecast period is 2019 to 2026.

Market Segmentation

By Products & Services (Reagents & Consumables, Instruments & Accessories, Software and Services), Applications (Clinical Diagnostics, Research & Development), End User (Hospitals, Clinical Laboratories, Pharmaceutical & Biotechnology Companies, Research Institutes, Others), Country (China, Japan, India, Australia, Singapore, Indonesia, Thailand, South Korea, Malaysia, Philippines, New Zealand, Vietnam, Rest of Asia-Pacific)
Some of the major factors contributing to the growth of the Asia-Pacific market:
? Improving healthcare infrastructure
? Increasing R&D expenditure in health care industry.
? Increasing cases of diseases and use in diagnostic purpose

Market Players

The key market players for Asia-Pacific PCR multiplex assays market are listed below:

? Thermo Fisher Scientific Inc.
? Luminex Corporation
? BD
? QIAGEN
? Agilent Technologies Inc.
? Meso Scale Diagnostics, LLC
? Randox Laboratories Ltd.
? Bio-Techne, Seegene Inc.
? Olink
? Illumina, Inc
? Bio-Rad Laboratories, Inc
? Abcam Plc
? Quanterix
? Sysmex Corporation
? Siemens
? F. Hoffmann-La Roche Ltd
? Hologic Inc
? Diasorin
? Abbott
? Quest Diagnostics Incorporated
? PerkinElmer Inc
? Eurofins Scientific
? Agena Bioscience, Inc.